Acumulado Enero - Diciembre 2023 (93 - 96) 93
ISSN 1317-987X
 
Buscar




Artículos
 




Anatomía Patológica
El carcinoma lobulillar de la mama y la inactivación del gen de la E-cadherina: revisión inmunohistoquímica sobre el origen de esta neoplasia

Referencias

  1. Foote FW, Stewart FW. Lobular carcinoma in situ: a rare form of mammary carcinoma. Am J Pathol 1941,17: 491-499.
  2. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia ( so- called lobular carcinoma in situ ) of the breast. Cancer 1978, 42: 737-769.
  3. Schniit SJ, Morrow M. Lobular carcinoma in situ: a current concept and controversies. Sem Diagn Pathol 1999, 16: 209-223.
  4. McDivitt RW, Hutter RPV, Foot FR y col. In situ lobular carcinoma : a prospective follow up study indicating cumulative patient risks. JAMA 1967, 201: 82-86.
  5. Hutter RPV. The management of patients with lobular carcinoma in situ of the breast. Cancer 1984, 53: 798-802.
  6. Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ y col. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997, 76: 1131-11343.
  7. Nayar R, Zhuang Z, Merino MJ, Silverberg SG. Loss of heteroczygocity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Hum Pathol 1997, 28: 277-282.
  8. Rieger-Christ KM, Pezza JA, Dugan JM, Braasch JW, Hughes KS, Summerhayes IC. Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas. J Clin Pathol:Mol Pathol 2001, 54: 91-97.
  9. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-Cadherin expresion in infiltrating ductal an lobular breast carcinomas. Am J Pathol 1993, 143: 1731-1742.
  10. Lerwill MF. Current practical applications of diagnostic immunohistoochemistry in breast pathology. Am J Surg Pathol 2004, 28: 1076-1091.
  11. Tavasoli FA. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 1998, 11: 140-154.
  12. Gupta SK, Douglas-Jones AC, Jasani B y col. E-Cadherin (e-cad) expresión in Duch carcinoma in situ (DCIS) of the breast. Virchows Arch 1997, 430: 23-28.
  13. De Leeuw WJ, Berx G, Vos CB y col. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997, 183: 404-411.
  14. Acs G, Lawton TJ, Reebecck TR y col. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001, 115: 534-542.
  15. Jacobs TW, Pliss N, Kouria G, Schnitt ST. Carcinoma in situ of the breast with indeterminate features. Am J Surg Pathol 2001, 25: 229-236.
  16. Maluf HM, Swanson PE, Koerner FC. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol 2001, 25: 237-244.
  17. Goldstein NS, Bassi D, Watts JC y col. E-cadherin reactivity of 95 non-invasive ductal and lobular lesions of the breast: implications for the interpretation of problematic lesions. Am J Clin Pathol 2001, 115: 534-542.
  18. Gamallo C, Palacios J, Suarez A y col. Correlation of E-cadherin expresión with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993, 142: 987-993.
  19. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993, 143: 1731-1742.
  20. Page DL, Kidd TE, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Human Pathol 1991, 22: 1232-1239.
  21. Habel LA, Moe RE, Daling JR, Holte S y col. Risk of contralateral breat cancer among women with carcinoma in situ of the breast. Ann Surg 1997, 225: 69-75.
  22. Goldstein NS, Kestin LL, Vicini FA. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast. Cancer 2001, 92: 738-747.
  23. Middleton LP, Grant S, Stephens T, Stelling CB y col. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol 2003, 16: 120-129.
  24. Koerner F, Maluf H. Uncommon morphologic patterns of lobular neoplasia. Ann Diagn Pathol 1999, 3: 249-259.
  25. Wheeler JE, Enterline HT, Roserman JM y col. Lobular carcinoma in situ of the breast. Long-term follow-up. Cancer 1974, 34: 554-563.
  26. Lakhani SR, van de Viijver MJ, Jacquemier J, Anderson TJ y col. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2 and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 2002, 20: 2310-2318.
  27. Schiint SJ, Morrow M. Lobular carcinoma in situ: current concepts and controversies. Sem Diagn Pathol 1999, 16: 209-223.
  28. Lakhani SR, Collins N, Sloane JP, Stratton MR, Houlston RS. Loss of heterocygocity in lobular carcinoma in situ of the breast. J Clin Pathol :Mol Pathol 1995, 48: M74-M78.
  29. Nayar R, Zhuang Z, Merino MJ, Silverberg SG. Loss of heterocygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Hum Pathol 1997, 28: 277-282.
  30. Dillon D, DÁquila T, Reynolds AB, Fearon ER, Rimm Dl. The expression of p120ctn protein in breast cancer is independent of a-and b-catenin and E-cadherin. Am J Pathol 1998, 152: 75-82.
  31. Hashizume R, Koizume H, Ihara A, Otha T, Uchikoshi T. Expression of Beta catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Histopathol 1996, 29: 139-146.
  32. Rosen PP. Coexistent lobular carcinoma in situ and intraductal carcinoma in a single lobular-duct unit. Am J Surg Pathol 1980, 4: 241-246.
  33. Sneige N, Wang J, Baker BA, Krishanamurthy S, Middleton LP. Clinical, histopathologic and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 2002, 15: 1044-1050.
  34. Bratthauer GL, Moinfar F, Stamatakos MD, Mezzaetti TP y col. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002, 32: 620-627.
  35. Fisher ER, Constantino J, Fisher B y col. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: five-year observations concerning lobular carcinoma in situ. Cancer 1996, 78: 1403-1416.
  36. Green I, Mc Cormick B, Cranor M y col. A comparative study of pure tubular and tubulolobular carcinoma of the breast. Am J Surg Pathol 1997, 21: 653-657.
Introducción
Materiales y métodos
Resultados
Discusión
Referencias

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit